The Claim
Apigenin suppresses CXCL10 expression in senescent human fibroblasts at levels comparable to IL-6 suppression, and this suppression is associated with reduced stimulation of breast cancer cell invasion and epithelial-mesenchymal transition.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin reduces the production of CXCL10 in aged human skin cells to a degree similar to its effect on IL-6, and this reduction is linked to decreased ability of breast cancer cells to invade surrounding tissue and change their identity.
See the scientific wording
Apigenin suppresses the novel SASP factor CXCL10 (IP10) in senescent human fibroblasts at levels comparable to IL-6, and this suppression is associated with reduced stimulation of breast cancer cell invasion and EMT.
Apigenin blocks a specific inflammatory signal chain in aging cells, which stops them from releasing a protein called CXCL10. Without this protein, nearby breast cancer cells lose their ability to spread and change into a more aggressive form.
What the research says
1 studyApigenin, a natural compound in some plants, reduces a harmful inflammatory signal (CXCL10) released by old cells, which in turn makes breast cancer cells less likely to spread. The study shows this happens directly in human cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.